We recently reported that an ablation catheter clinical trial would potentially usher in FDA approval of the first device for treating atrial fibrillation. That approval was just granted today when the NAVISTAR® THERMOCOOL® Catheter from Biosense Webster (Johnson & Johnson) was approved by the FDA for catheter ablation of atrial fibrillation. Finally, a step in …
One of the many studies reported on this week at the American Heart Association Scientific Sessions in New Orleans was about an ablation catheter clinical trial (from Biosense Webster) that may finally usher in the first FDA approval of a device for treating atrial fibrillation. Read why this could be good news for anyone with …
